PHILIP HOFMAN: Open Payments
NPI 1861021107 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 21 payments from 6 companies in 2025. Trend: 2023 $1,314 · 2024 $396 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 11 | $641 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| MML US, Inc. | 2 | $46 |
| Globus Medical, Inc. | 1 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Curonix LLC | 1 | $15 |
Products named: General - Therapies, Intracept, Belbuca, Fixate, ReActiv8, Senza, RELISTOR, General - Pain Management.
Industry payments across FL — which companies pay providers there.
